Technical Analysis for VCYT - Veracyte, Inc.

Grade Last Price % Change Price Change
grade A 29.0 -1.83% -0.54
VCYT closed down 1.83 percent on Friday, July 10, 2020, on 53 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: Jul 30
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical VCYT trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Stochastic Sell Signal Bearish -1.83%
Doji - Bearish? Reversal -1.83%
Upper Bollinger Band Walk Strength -1.83%
Overbought Stochastic Strength -1.83%
Upper Bollinger Band Touch Strength -1.83%
180 Bullish Setup Bullish Swing Setup -1.59%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier (GEC), which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignant GEC test for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Organ Systems Gene Expression Idiopathic Pulmonary Fibrosis Lung Cancer Surgeries Glands Thyroid Cancer Thyroid

Is VCYT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.18
52 Week Low 13.9
Average Volume 474,036
200-Day Moving Average 25.42
50-Day Moving Average 26.21
20-Day Moving Average 26.39
10-Day Moving Average 27.29
Average True Range 1.48
ADX 14.13
+DI 29.03
-DI 19.17
Chandelier Exit (Long, 3 ATRs ) 25.42
Chandelier Exit (Short, 3 ATRs ) 27.13
Upper Bollinger Band 30.11
Lower Bollinger Band 22.66
Percent B (%b) 0.85
BandWidth 28.27
MACD Line 0.93
MACD Signal Line 0.49
MACD Histogram 0.4351
Fundamentals Value
Market Cap 982.9 Million
Num Shares 33.9 Million
EPS -0.80
Price-to-Earnings (P/E) Ratio -36.25
Price-to-Sales 3.94
Price-to-Book 5.91
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.96
Resistance 3 (R3) 31.02 30.43 30.64
Resistance 2 (R2) 30.43 29.93 30.40 30.53
Resistance 1 (R1) 29.72 29.62 29.42 29.65 30.42
Pivot Point 29.12 29.12 28.97 29.09 29.12
Support 1 (S1) 28.41 28.62 28.11 28.35 27.58
Support 2 (S2) 27.81 28.31 27.78 27.47
Support 3 (S3) 27.10 27.81 27.37
Support 4 (S4) 27.04